University of South Australia
Adelaide, Australia
Purpose
to pre-clinically validate a molecular treatment for the control and prevention of preeclampsia using short interfering RNAs delivered to target cells via a high-density lipoprotein nanocarrier
Division
Global Health
Date
November 2019
Region Served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
36
Grantee location
Adelaide, Australia
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.